Special Issue "Cancer Biomarker Research and Personalized Medicine"

被引：0
作者：
Meehan, James [1 ]
机构：
[1] Univ Edinburgh, Inst Genet & Canc, Western Gen Hosp, Translat Oncol Res Grp, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 04期
关键词：
TUMOR; CARCINOMA; DIAGNOSIS; CELLS;
D O I：
10.3390/jpm12040585
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 22 条
  • [1] Identification of Novel Mutations in Colorectal Cancer Patients Using AmpliSeq Comprehensive Cancer Panel
    Almuzzaini, Bader
    Alghamdi, Jahad
    Alomani, Alhanouf
    AlGhamdi, Saleh
    Alsharm, Abdullah A.
    Alshieban, Saeed
    Sayed, Ahood
    Alhejaily, Abdulmohsen G.
    Aljaser, Feda S.
    Abudawood, Manal
    Almajed, Faisal
    Samman, Abdulhadi
    Al Balwi, Mohammed A.
    Aziz, Mohammad Azhar
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [2] Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer
    Benitez, Jose Carlos
    Campayo, Marc
    Diaz, Tania
    Ferrer, Carme
    Acosta-Plasencia, Melissa
    Monzo, Mariano
    Cirera, Luis
    Besse, Benjamin
    Navarro, Alfons
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05):
  • [3] Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
    Chang, Pei-Hung
    Wang, Hung-Ming
    Kuo, Yung-Chia
    Lee, Li-Yu
    Liao, Chia-Jung
    Kuo, Hsuan-Chih
    Hsu, Cheng-Lung
    Liao, Chun-Ta
    Lin, Sanger Hung-Chi
    Huang, Pei-Wei
    Wu, Tyler Min-Hsien
    Hsieh, Jason Chia-Hsun
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
  • [4] GBP5 Serves as a Potential Marker to Predict a Favorable Response in Triple-Negative Breast Cancer Patients Receiving a Taxane-Based Chemotherapy
    Cheng, Shun-Wen
    Chen, Po-Chih
    Ger, Tzong-Rong
    Chiu, Hui-Wen
    Lin, Yuan-Feng
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (03):
  • [5] Circulating Tumor Cell Detection during Neoadjuvant Chemotherapy to Predict Early Response in Locally Advanced Oropharyngeal Cancers: A Prospective Pilot Study
    Gauthier, Arnaud
    Philouze, Pierre
    Lauret, Alexandra
    Alphonse, Gersende
    Malesys, Celine
    Ardail, Dominique
    Payen, Lea
    Ceruse, Philippe
    Wozny, Anne-Sophie
    Rodriguez-Lafrasse, Claire
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (03):
  • [6] Predictive and Diagnostic Biomarkers of Anastomotic Leakage: A Precision Medicine Approach for Colorectal Cancer Patients
    Gray, Mark
    Marland, Jamie R. K.
    Murray, Alan F.
    Argyle, David J.
    Potter, Mark A.
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [7] Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
    Guldvik, Ingrid Jenny
    Ekseth, Lina
    Kishan, Amar U.
    Stensvold, Andreas
    Inderberg, Else Marit
    Lilleby, Wolfgang
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (07):
  • [8] Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer
    Ingrosso, Gianluca
    Ali, Emanuele
    Marani, Simona
    Saldi, Simonetta
    Bellavita, Rita
    Aristei, Cynthia
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
  • [9] Detection of Aberrant Glycosylation of Serum Haptoglobin for Gastric Cancer Diagnosis Using a Middle-Up-Down Glycoproteome Platform
    Jeong, Seunghyup
    Kim, Unyong
    Oh, Myungjin
    Nam, Jihyeon
    Park, Sehoon
    Choi, Yoonjin
    Lee, Dongho
    Kim, Jaehan
    An, Hyunjoo
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [10] Associations between the Levels of Estradiol-, Progesterone-, and Testosterone-Sensitive MiRNAs and Main Clinicopathologic Features of Breast Cancer
    Kalinina, Tatiana
    Kononchuk, Vladislav
    Alekseenok, Efim
    Abdullin, Grigory
    Sidorov, Sergey
    Ovchinnikov, Vladimir
    Gulyaeva, Lyudmila
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
123